Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides a commercial infrastructure foundation for future product launches.
Lead Product(s): Amino Acids Mixture,Minerals,Vitamins
Therapeutic Area: Genetic Disease Product Name: PKU Golike
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Relief Therapeutics
Deal Size: $72.2 million Upfront Cash: $23.3 million
Deal Type: Acquisition June 29, 2021
Details:
First mix of amino acids having a pharmacological primary mode of action designed to reduce and control Phenylalanine fluctuations.
Lead Product(s): APR-OD031
Therapeutic Area: Genetic Disease Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 26, 2020